INSIDER · CIK 1613867
Behbahani Ali
Director at CRISPR Therapeutics AG (CRSP) · Director at Black Diamond Therapeutics, Inc. (BDTX)
↗4 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$781KSold on the market
2Companies
Sep 21, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 21, 202618:40 | Sep 17, 2026 | CRSPCRISPR Therapeutics AG | Director | S · Sell | $57.09 | −13,679 | 16,637 | -45% | −$781K | ||
| Sep 21, 202618:40 | Sep 17, 2026 | CRSPCRISPR Therapeutics AG | Director | M · Exercise | $14.00 | +30,000 | 30,316 | +9494% | $420K | ||
| Sep 21, 202618:30 | Aug 6, 2025 | CRSPCRISPR Therapeutics AG | Director | J · OtherLate 411d | — | +75 | 316 | +31% | — | ||
| Sep 21, 202617:45 | Sep 18, 2026 | BDTXBlack Diamond Therapeutics, Inc. | Director | A · Grant | $1.93 | +7,707 | 110,236 | +8% | $15K |